Cefepime for Injections USP and Dextrose Injection USP, 1 g in Duplex, 50 mL Container, Catalog Number 3193-11, For IV Use Only, Single Dose, Sterile, Rx Only, B Braun Medical Inc., Irvine CA 92614-5895, NDC 0264-3193-11
Published May 7, 2014 · Recall initiated: November 21, 2013
Summary
FDA records drug Class I recall D-1267-2014, published May 7, 2014 and initiated November 21, 2013. Recalling firm: B. Braun Medical Inc; Status: Terminated; Reported quantity: 22,248 units; Lot: Lot# H2L712, Exp 09/14. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.
What to do
Voluntary: Firm initiated · Letter
Get an email if CEFEPIME HYDROCHLORIDE AND DEXTROSE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CEFEPIME HYDROCHLORIDE AND DEXTROSE
- Manufacturer
- B. Braun Medical Inc
- Distributor
- Nationwide, Puerto Rico and Spain
- Lot
- Lot# H2L712, Exp 09/14
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACeftriaxone for Injection and Dextrose Injection, 1 g in Duplex, 50 mL Container, Catalog Number 3153-11, ForMay 7, 2014
- FDACefazolin for Injection USP and Dextrose Injections USP, 1 g in Duplex, 50 mL Container, Catalog NumberMay 7, 2014
- FDA0.9 % Sodium Chloride Injection USP in PAB 50 mL partial fill in 100 mL PAB Container, Catalog No. S8004-5384,May 7, 2014
- FDACefazolin for Injection USP and Dextrose Injection USP, 2 g in Duplex, 50 mL Container, Catalog NumberMay 7, 2014
- FDACefoxitin for Injection and Dextrose Injection, 1 g in Duplex, 50 mL Container, Catalog No. 3123-11, For IVMay 7, 2014
- FDACefepime for Injection USP and Dextrose Injection USP, in Duplex Drug Delivery System, 1 g in 50 mL duplexFebruary 12, 2014
Questions about this recall
Was Cefepime for Injections USP and Dextrose Injection USP, 1 g in Duplex, 50 mL Container, Catalog Number 3193-11, For IV Use Only, Single Dose, Sterile, Rx Only, B Braun Medical Inc., Irvine CA 92614-5895, NDC 0264-3193-11 recalled?
Yes. FDA published recall D-1267-2014 on May 7, 2014. Reported hazard: Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CEFEPIME HYDROCHLORIDE AND DEXTROSE.